Skip navigation
Skip navigation

Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab

Roohullah, Aflah; Wong, Hui-Li; Sjoquist, Katrin M; Gibbs, Peter; Field, Kathryn; Tran, Ben; Shapiro, Jeremy; Mckendrick, Joe; Yip, Desmond; Nott, Louise; Gebski, Val; Ng, Weng; Chua, Wei; Price, Timothy; Tebbutt, Niall; Chantrill, Lorraine


AIM To investigate the safety and efficacy of adding bevacizumab to first-line chemotherapy in metastatic colorectal cancer patients with peritoneal disease. METHODS We compared rates of gastrointestinal perforation in patients with metastatic colorectal cancer and peritoneal disease receiving first-line chemotherapy with and without bevacizumab in three distinct cohorts: (1) the AGITG MAX trial (Phase III randomised clinical trial comparing capecitabine vs capecitabine and bevacizumab vs...[Show more]

CollectionsANU Research Publications
Date published: 2015-05-07
Type: Journal article
Source: World journal of gastroenterology:WJG
DOI: 10.3748/wjg.v21.i17.5352


File Description SizeFormat Image
Roohullah, A et al Gastrointestinal perforation in metastatic 2015.pdf886.73 kBAdobe PDFThumbnail

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  20 July 2017/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator